GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Price-to-Tangible-Book

Hanall Biopharma Co (XKRX:009420) Price-to-Tangible-Book : 14.01 (As of Jul. 22, 2025)


View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co Price-to-Tangible-Book?

As of today (2025-07-22), Hanall Biopharma Co's share price is ₩28650.00. Hanall Biopharma Co's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was ₩2,045.50. Hence, Hanall Biopharma Co's Price to Tangible Book Ratio of today is 14.01.

The historical rank and industry rank for Hanall Biopharma Co's Price-to-Tangible-Book or its related term are showing as below:

XKRX:009420' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 5.14   Med: 10.04   Max: 16.84
Current: 14.01

During the past 13 years, Hanall Biopharma Co's highest Price to Tangible Book Ratio was 16.84. The lowest was 5.14. And the median was 10.04.

XKRX:009420's Price-to-Tangible-Book is ranked worse than
94% of 834 companies
in the Drug Manufacturers industry
Industry Median: 2.53 vs XKRX:009420: 14.01

A closely related ratio is called PB Ratio. As of today, Hanall Biopharma Co's share price is ₩28650.00. Hanall Biopharma Co's Book Value per Sharefor the quarter that ended in Mar. 2025 was ₩3,136.42. Hence, Hanall Biopharma Co's P/B Ratio of today is 9.13.


Hanall Biopharma Co Price-to-Tangible-Book Historical Data

The historical data trend for Hanall Biopharma Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Price-to-Tangible-Book Chart

Hanall Biopharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.55 7.46 6.25 14.62 16.84

Hanall Biopharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.16 12.15 15.73 16.84 13.42

Competitive Comparison of Hanall Biopharma Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Hanall Biopharma Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanall Biopharma Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanall Biopharma Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Hanall Biopharma Co's Price-to-Tangible-Book falls into.


;
;

Hanall Biopharma Co Price-to-Tangible-Book Calculation

Hanall Biopharma Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2025 )
=28650.00/2045.502
=14.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Hanall Biopharma Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanall Biopharma Co Business Description

Traded in Other Exchanges
N/A
Address
12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR
Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co Headlines

No Headlines